References:
  1. Zoni-Berisso M, Lercari F, Carazza T, Domenicucci S. Epidemiology of atrial fibrillation: European perspective. Clin Epidemiol 2014;6:213–20.
  2. Steinbeck G, Sinner MF, Lutz M, Muler-Nurasyid, Kaab S, Reinecke H. Incidence of complications related to catheter ablation of atrial fibrillation and atrial flutter: a nationwide in-hospital analysis of administrative data for Germany in 2014. Eur Heart J 2018;39:4020–29.
  3. Stabile G, Bertaglia E, Pappone C, Themistoclakis S, Tondo C, Zorzi Aet al . Influence of age and gender on complications of catheter ablation for atrial fibrillation. J Atr Fibrillation 2015;7 :1197.
  4. Shah RU, Freeman JV, Shilane D, Wang PJ, Go AS, Hlatky MA. Procedural complications, rehospitalizations, and repeat procedures after catheter ablation for atrial fibrillation. J Am Coll Cardiol 2012;59:143–49.
  5. Calkins H, Hindricks G, Cappato R, Kim YH, Saad EB, Aguinaga Let al . 2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation. Europace 2018;20:e1–e160.
  6. Aldhoon B, Wichterle D, Peichl P, Čihák R, Kautzner J. Complications of catheter ablation for atrial fibrillation in a high-volume centre with the use of intracardiac echocardiography. Europace 2013;15:24–32.
  7. Cheung JW, Cheng EP, Wu X, Yeo I, Christos PJ, Kamel H et al . Sex-based differences in outcomes, 30-day readmissions, and costs following catheter ablation of atrial fibrillation: the United States Nationwide Readmissions Database 2010-14. Eur Heart J 2019;40:3035–43.
  8. Kaiser DW, Fan J, Schmitt S, Than CT, Ullal AJ, Piccini JP et al . Gender differences in clinical outcomes after catheter ablation of atrial fibrillation. JACC Clin Electrophysiol 2016;2:703–10.
  9. Spragg DD, Dalal D, Cheema A, Scherr D, Schilukuri K, Cheng A et al. Complications of catheter ablation for atrial fibrillation: Incidence and predictors. J Cardiovasc Electrophysiol 2008;19:627–31.
  10. Patel D, Mohanty P, Di Biase L, Sanchez JE, Shaheen MH, Burkhardt JDet al. Outcomes and complications of catheter ablation for atrial fibrillation in females. Heart Rhythm 2010;7:167–72.
  11. Zhang XD, Tan HW, Gu J, Jiang WF, Zhao L, Wang YL et al.Efficacy and safety of catheter ablation for long-standing persistent atrial fibrillation in women. Pacing Clin Electrophysiol 2013;36:1236–44.
  12. Dagres N, Hindricks G, Kottkamp H, Sommer P, Gaspar T, Bode K et al . Complications of atrial fibrillation in 1000 consecutive procedures: still cause for concern? J Cardiovasc Electrophysiol 2009;20:1014–9.
  13. Gupta A, Perera T, Ganesan A, Sullivan T, Lau DH, Roberts-Thomson KCet al . Complications of catheter ablation of atrial fibrillation: a systematic review. Circ Arrhythm Electrophysiol 2013;6:1082–8.
  14. Argulian E, Patel AD, Abramson JL, Kulkarni A, Champney K, Palmer Set al. Gender differences in short-term cardiovascular outcomes after percutaneous coronary interventions. Am J Cardiol 2006;98:48–53.
  15. Sharma V, Wilson W, Smith W, McEntegart M, Oldroyd K, Sidik N et al. Comparison of characteristics and complications in men versus women undergoing chronic total occlusion percutaneous intervention. Am J Cardiol 2017;119:535–41.
  16. McCaughan GJB, Favaloro EJ, Psalic L, Curnow J. Anticoagulation at the extremes of body weight: choices and dosing. Expert Rev Hematol 2018;11:817–28.
  17. Campbell NR, Hull RD, Brant R, Hogan DB, Pineo GF, Raskob GE. Different effects of heparin in males and females. Clin Invest Med 1998;21:71–8.
  18. Piper WD, Malenka DJ, Ryan TJ jr, Shuhbrooks SJ jr, O’Connor GT, Robb JF el al . Predicting vascular complications in percutaneous coronary interventions. Am Heart J 2003;145:1022–9.
  19. Winkle RA, Mead RH, Engel G, Patrawala RA. Safety of lower activated clotting times during atrial fibrillation ablation using open irrigated tip catheters and a single transseptal puncture. Am J Cardiol 2011;107: 704-8
  20. Uhl JF, Gillot C, Chahim M. Anatomical variations of the femoral vein. J Vasc Surg 2010;52:714–9.
  21. Czyzewska D, Ustymowicz A, Kowalewski R, Zurada A, Krejza J. Cross-sectional area of the femoral vein varies with leg position and distance from the inguinal ligament. Plos One 2017;12: 1–11.
  22. Sharma P, Padala S, Gunda S, Koneru JN, Ellenbogen KA. Vascular complications during catheter ablation of cardiac arrhythmias: a comparison between vascular ultrasound guided access and conventional vascular access. J Cardiovasc Electrophysiol. 2016;27:1160–6.
  23. Mohanty S, Trivedi C, Gianni C, Burkhardt J, Sanchez R et al. Real-time ultrasound guidance for venous access reduces vascular complications in women aged 75 years or older undergoing catheter ablation for atrial fibrillation under uninterrupted anticoagulation. Eur Heart J 2018;39:suppl 1,P5755
  24. Yamagata K, Wichterle D, Roubíček T, Jarkovský P, Sato J Kogure T et al. Ultrasound-guided versus conventional femoral venipuncture for catheter ablation of atrial fibrillation: a multicentre randomized efficacy and safety trial (ULTRA-FAST trial). Europace 2018;7:1107-1114.
  25. Sobolev M, Shiloh AL, Di Biase L, Slovut DP. Ultrasound-guided cannulation of the femoral vein in electrophysiological procedures: a systematic review and meta-analysis. Europace 2017;5:850-855.
  26. Kupó P, Pap R, Sághy L, Tényi D, Bálint A, Debreceni D et al. Ultrasound guidance for femoral venous access in electrophysiology procedures-systematic review and meta-analysis. J Interv Card Electrophysiol 2019;10:s10840-019-00683.
  27. Yang P, Wang C, Ye Y, Huang T, Yang S, Shen W et al. Interrupted or uninterrupted oral anticoagulants in patients undergoing atrial fibrillation ablation. Cardiovasc Drugs Ther 2020;34:371-381
Table 1. Baseline characteristics of the study population